Delius Group’s business segments, as presented in the circle graph above: biosimilars, generics, APIs, CDMO, and institutional business.
MUMBAI: Delius Pharma, a powerhouse in the pharmaceutical industry, continues to make waves with its strategic initiatives and impressive growth trajectory. The company’s recent Q1 performance not only showcased robust results across key sectors but also highlighted its ambitious plans for expansion and innovation.
Investment Talks with VCs
Delius Pharma is currently in talks with venture capitalists to secure global investments, aiming to bolster its market position and accelerate growth initiatives. These discussions are poised to attract substantial funding, positioning Delius Pharma as a leader in pharmaceutical innovation and development.
Expansion into CDMO Services
In a bid to diversify its service offerings, Delius Pharma is gearing up to launch Contract Development and Manufacturing Organization (CDMO) services. With numerous approvals underway for over 5000 products, Delius Pharma aims to disrupt the CDMO market, leveraging its expertise and infrastructure to meet growing industry demands.
Diverse Business Segments
Delius Pharma’s success is underscored by its diverse portfolio of business segments:
Biosimilar Division: Leading advancements in biosimilar medicines, catering to evolving healthcare needs.
Generics Formulation Division: Pioneering affordable healthcare solutions with a focus on quality and accessibility.
API Division: Innovating in active pharmaceutical ingredients, ensuring high standards of production and efficiency.
CDMO Division: Soon to be launched, poised to offer comprehensive development and manufacturing solutions.
Institutional Division: Partnering with hospitals to provide specialized healthcare solutions, enhancing patient care nationwide.
Future Prospects and Acquisitions
Looking ahead, Delius Pharma eyes strategic acquisitions in Uttarakhand, targeting 2 to 3 companies to further strengthen its market presence and expand operational capabilities. These moves align with Delius Pharma’s vision to lead the pharmaceutical industry through innovation, excellence, and strategic growth.
Delius Pharma continues to set benchmarks in the pharmaceutical sector, driving forward with a commitment to excellence and a vision for a healthier future.
